Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04409886 · ClinicalTrials.gov registry record · Phase 4
Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients
A Phase 4 study, sponsored by Maimonides Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT04409886 is a Phase 4 study that was terminated before completion, run by Maimonides Medical Center. The registered enrollment target is 1 participants.
The verdict
NCT04409886, a Phase 4 study, was terminated before completion, sponsored by Maimonides Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study is a prospective randomized controlled, double blind clinical trial performed on laboratory confirmed COVID-19 infection admitted patients in the Shamir Medical Center. The trial will include 30 patients who will undergo either hyperbaric oxygen therapy (HBOT) or Normobaric oxygen therapy (NBOT), randomized on a 2:1 ratio, within 4 days in addition to the standard treatment including oxygen, drugs, steroids, bronchodilators, antibiotics and others. The evaluation procedure includes symptom monitoring, room air saturation, vital signs monitoring, pulmonary function and blood tests at baseline, one day and one week after the last session. In addition, one hour prior to and post session saturation and vitals will be monitored.
Interventions
- BIOLOGICAL Hyperbaric Oxygen Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2020-06-01 |
| Est. Completion | 2021-01-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04409886
The ClinicalTrials.gov registry entry for NCT04409886 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Maimonides Medical Center, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hyperbaric Oxygen Therapy is the first listed.
NCT04409886 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04409886 about?
NCT04409886 is a clinical study titled "Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients". This study is a prospective randomized controlled, double blind clinical trial performed on laboratory confirmed COVID-19 infection admitted patients in the Shamir Medical Center. The trial will include 30 patients who will undergo either hyperbaric oxygen therapy (HBOT) or Normobaric oxygen therapy...
What is the current status of trial NCT04409886?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2020-06-01. Estimated completion is 2021-01-31.
What interventions are being tested in trial NCT04409886?
The interventions under investigation include: Hyperbaric Oxygen Therapy (BIOLOGICAL).
Who is sponsoring clinical trial NCT04409886?
This trial is sponsored by Maimonides Medical Center, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.